A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia
Faisal M. Sanai(King Abdulaziz Medical City), Faleh Z. Al-Faleh, Devin Razavi‐Shearer(University of London), Homie Razavi(Center for Disease Analysis), Jonathan Schmelzer(Center for Disease Analysis), Nasser AlMasri(Riyadh Armed Forces Hospital), Waleed Al–Hamoudi(King Saud University), Ellen Dugan(Center for Disease Analysis), Mohammed Alghamdi(King Fahd Military Medical Complex), Abduljaleel Alalwan, Faisal Abaalkhail(Alfaisal University)
Cited by 28
Related Papers
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
|Journal of Hepatology|2018|2k
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
|The Lancet. Gastroenterology & hepatology|2023|399